|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tetrasodium pyrophosphate | CAS 7722-88-5 | ||
| Na4P2O7 | RTECS UX7350000 | ||
|
Synonyms & Trade Names Pyrophosphate, Sodium pyrophosphate, Tetrasodium diphosphate, Tetrasodium pyrophosphate (anhydrous), TSPP |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 5 mg/m3 | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Odorless, white powder or granules. [Note: The decahydrate (Na4P2O7 • 10H2O) is in the form of colorless, transparent crystals.] |
|||
|
MW: 265.9 |
BP: Decomposes |
MLT: 1810°F |
Sol(77°F): 7% |
|
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 2.45 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Strong acids |
|||
|
Measurement Methods NIOSH 0500 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash (solution) |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, nose, throat; dermatitis | |
|
Target Organs
Eyes, skin, respiratory system |
|
| See also: INTRODUCTION |